Merck and Orna Therapeutics' deal to collaborate on RNA technology was the big pharma deal of August, and could be worth up to $3.5bn in total depending on whether Orna meets certain development, regulatory and sales milestones. (Also see "Merck Buys Into Orna's Circular RNA Platform With Emphasis On Vaccines" - Scrip, 16 August, 2022.)
In the medical device space, United Imaging Healthcare raised a hefty $1.6bn in its IPO and in diagnostics, Bio-Rad fully acquired Curiosity Diagnostics for $170m.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?